SCHEMBL9925840

SCHEMBL9925840

C=C(NC(C(=O)NO)C(C)O)c1ccc(C#CC#Cc2ccc(NC(=O)CN(C)C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1105535 0.91
SCHEMBL403188 0.91
SCHEMBL1105550 0.91
SCHEMBL402607 0.87
SCHEMBL13655043 0.83 ACACB (0.41) MAPT
SCHEMBL13654995 0.82
SCHEMBL399083 0.82 PPARG (0.39)
SCHEMBL13655041 0.81 HDAC1 (0.41) MAPT
SCHEMBL13655039 0.80 LMNA (0.38)
SCHEMBL14033890 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1618087-B1 ANTIBACTERIAL AGENTS NOVARTIS VACCINES & DIAGNOSTIC (US) 2012-06-13 EP disclosed